Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advance Solid Tumors”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Not applicableLooking for participantsNCT06795815
What this trial is testing

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

Who this might be right for
LeukemiaMultiple MielomaAdvanced Solid Tumors+3 more
Azienda USL Reggio Emilia - IRCCS 75
Early research (Phase 1)Looking for participantsNCT07229313
What this trial is testing

KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advance Solid Tumors
Kivu Bioscience Inc. 76
Not applicableStudy completedNCT01817686
What this trial is testing

Study of Default Options in Advance Directives

Who this might be right for
COPDSevere or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen TherapyIdiopathic Pulmonary Fibrosis+5 more
Corporal Michael J. Crescenz VA Medical Center 62
Early research (Phase 1)Ended earlyNCT05621525
What this trial is testing

Phase I Study of the BBP-398 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced or Metastatic Non-small Cell Lung Cancer
LianBio LLC 7
Early research (Phase 1)Study completedNCT01653158
What this trial is testing

CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies

Who this might be right for
Advanced Non-Hematologic Malignancies
Pfizer 46
Early research (Phase 1)Study completedNCT01213381
What this trial is testing

Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors

Who this might be right for
Advance Solid Tumors
Sanofi 18
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262466
What this trial is testing

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Who this might be right for
Select Advanced Solid Tumors
Immunocore Ltd 410
Early research (Phase 1)Study completedNCT04850755
What this trial is testing

A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Advanced/Metastatic Solid Malignancies

Who this might be right for
Advance Solid MalignanciesMetastatic Solid Malignancies
National University Hospital, Singapore 11
Testing effectiveness (Phase 2)Looking for participantsNCT06249048
What this trial is testing

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Who this might be right for
Advanced Solid Tumor
Strand Therapeutics Inc. 108
Early research (Phase 1)Study completedNCT01582997
What this trial is testing

A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors

Who this might be right for
Cancer
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Early research (Phase 1)Study completedNCT01418677
What this trial is testing

An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Eisai Inc. 19
Early research (Phase 1)Study completedNCT00997945
What this trial is testing

10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 15
Testing effectiveness (Phase 2)Ended earlyNCT05008445
What this trial is testing

Study of LM-102 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Development Co., Ltd. 11
Early research (Phase 1)Study completedNCT00426140
What this trial is testing

Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.

Who this might be right for
Advanced MalignanciesSolid Tumors
Novartis Pharmaceuticals 5
Early research (Phase 1)Study completedNCT02301117
What this trial is testing

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 43
Not applicableLooking for participantsNCT04515810
What this trial is testing

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Who this might be right for
Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 400
Testing effectiveness (Phase 2)Study completedNCT05161390
What this trial is testing

Study of LM-302 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Zhejiang Co., Ltd. 153
Load More Results